GLPBio

Cardiovascular

Read More about this category
Cardiovascular

Cardiovascular

The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment.

Research Areas

Products Related to Cardiovascular(821)

  • GC41882 structure
    GC4188212(S)-HETrE
    CAS: 72710-10-2
    Purity: >98.00%

    12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).

  • GC41893 structure
    GC4189313(R)-HODE cholesteryl ester
    CAS: 330800-94-7
    Purity: >98.00%

    13(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.

  • GC41895 structure
    GC4189513(S)-HODE cholesteryl ester
    CAS: 141554-21-4
    Purity: >98.00%

    13(S)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.

  • GC41897 structure
    GC4189713(S)-HOTrE
    CAS: 87984-82-5
    Purity: >98.00%

    13(S)-HOTrE is the 15-lipoxygenase (15-LO) product of linolenic acid.

  • GC41935 structure
    GC4193515-keto Treprostinil (sodium salt)
    Purity: >98.00%

    15-keto Treprostinil is an impurity found in treprostinil, which is a stable analog of prostaglandin I2 with a longer plasma half-life.

  • GC42008 structure
    GC420081-Octadecyl Lysophosphatidic Acid
    CAS: 52977-29-4
    Purity: >95.00%

    1-Octadecyl lysophosphatidic acid (1-octadecyl LPA) is a LPA analog containing stearic acid at the sn-1 position.

  • GC42065 structure
    GC420652,3-dinor Thromboxane B1
    CAS: 196493-76-2
    Purity: >98.00%

    Thromboxane B2 (TXB2) is released in substantial quantities from aggregating platelets and metabolized during circulation to 11-dehydro TXB2 and 2,3-dinor TXB2.

  • GC42135 structure
    GC421352-chloro Palmitic Acid
    CAS: 19117-92-1
    Purity: >95.00%

    2-ChlorpalmitinsÄure, ein entzÜndlicher Lipidmediator, stÖrt die Proteinpalmitylierung, induziert ER-Stressmarker, reduziert den ER-ATP-Gehalt und aktiviert die Transkription und Sekretion von IL-6 sowie IL-8.2-ChlorpalmitinsÄure stÖrt die Mitochondrien Membranpotential und induziert die Procaspase-3- und PARP-Spaltung. 2-ChlorpalmitinsÄure kann die Blut-Hirn-Schranke (BBB) Überwinden und beeintrÄchtigt ER- und Mitochondrienfunktionen in der Endothelzelllinie hCMEC/D3 des menschlichen Gehirns.

  • GC42160 structure
    GC421602-furoyl-LIGRLO amide (trifluoroacetate salt)
    Purity: >95.00%

    2-furoyl-LIGRLO amide is a potent and selective agonist of the proteinase-activated receptor, PAR2 (pD2 = 7.0).

  • GC42189 structure
    GC421892-oxo Clopidogrel
    CAS: 109904-27-0
    Purity: >98.00%

    2-oxo Clopidogrel is an intermediary metabolite of clopidogrel.

  • GC42338 structure
    GC423384-Aminobenzoic Acid hydrazide
    CAS: 5351-17-7
    Purity: >99.00%

    4-AminobenzoesÄurehydrazid ist ein irreversibler MPO-Myeloperoxidase-Hemmer mit einem IC50-Wert von 0,3 μM.

  • GC42405 structure
    GC424054-hydroxy Atorvastatin (calcium salt)
    CAS: 265989-44-4
    Purity: >90.00%

    4-hydroxy Atorvastatin is a metabolite of atorvastatin, an HMG-CoA reductase inhibitor present in formulations that have been used to treat hypercholesterolemia and certain dyslipidemias.

  • GC42409 structure
    GC424094-hydroxy Nebivolol (hydrochloride)
    CAS: 2717115-85-8
    Purity: >98.00%

    4-hydroxy Nebivolol is a major metabolite of nebivolol.

  • GC42411 structure
    GC424114-hydroxy Nonenal Alkyne
    CAS: 1011268-23-7
    Purity: >98.00%

    4-hydroxy Nonenal (4-HNE) is a major aldehyde produced during the lipid peroxidation of ω-6 polyunsaturated fatty acids, such as arachidonic acid and linoleic acid.

  • GC42498 structure
    GC424985-chloro Hydrochlorothiazide
    CAS: 5233-42-1
    Purity: >98.00%

    5-chloro Hydrochlorothiazide is a derivative of hydrochlorothiazide, which is a diuretic and antihypertensive agent that increases renal excretion of sodium, potassium, chloride, and bicarbonate ions by inhibiting tubular reabsorptive mechanisms.

  • GC42548 structure
    GC425485-hydroxy Saxagliptin (hydrochloride)
    Purity: >95.00%

    5-hydroxy Saxagliptin is a major active metabolite of saxagliptin.

  • GC42563 structure
    GC425635-methyl-2-HOBA (hydrochloride)
    CAS: 2044714-53-4
    Purity: >98.00%

    5-methyl-2-HOBA is an isoketal scavenger.

  • GC42634 structure
    GC426349(R)-HODE cholesteryl ester
    CAS: 330800-93-6
    Purity: >98.00%

    9(R)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.

  • GC42635 structure
    GC426359(S)-HODE cholesteryl ester
    CAS: 143442-54-0
    Purity: >98.00%

    9(S)-HODE cholesteryl ester was originally extracted from atherosclerotic lesions.

  • GC42690 structure
    GC42690Acecainide (hydrochloride)
    CAS: 34118-92-8
    Purity: >98.00%

    Acecainide is an active metabolite of the class III antiarrhythmic procainamide.

  • GC42738 structure
    GC42738Adrenomedullin (13-52) (human) (trifluoroacetate salt)
    Purity: >95.00%

    Adrenomedullin (13-52) is a truncated form of adrenomedullin (1-52).

  • GC42739 structure
    GC42739Adrenomedullin (1-50) amide (rat) (trifluoroacetate salt)
    Purity: >95.00%

    Adrenomedullin (1-50) is a peptide hormone with RNA expressed in rat adrenal glands, lung, kidney, heart, and spleen, as well as in the duodenum and submandibular glands.

  • GC42740 structure
    GC42740Adrenomedullin (1-52) (human) (trifluoroacetate salt)
    Purity: >95.00%

    Adrenomedullin (1-52) is a peptide with diverse biological activities.

  • GC42746 structure
    GC42746AFP 07 (free acid)
    CAS: 788799-13-3
    Purity: >98.00%

    Prostaglandin I2 is an unstable prostanoid which, through the 'I prostanoid' (IP) receptor, inhibits platelet aggregation and promotes vasodilatation in pulmonary vascular beds.